Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-20

Clinical Trial Update: Efficacy and Safety of Resveratrol and Carbossimetyl Beta Glucan in Treatment of Upper Airways Disease in Infancy [Phase 3]

View source ↗

Summary

Phase 3 trial assessing efficacy and safety of resveratrol combined with carbossimetyl beta glucan for upper airway disease (common cold) in infancy has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbossimetyl Beta Glucan (Carbossimetyl Beta Glucan)
  • Resveratrol (resveratrol)

Snippet

Sponsor: Policlinico Hospital | Conditions: Common Cold | Phase 3 | Status: COMPLETED